The acquisition includes dsm-firmenich's Marine Lipids omega-3 fish oil business for the food and beverage, dietary supplement and pharmaceutical markets, ...

The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two ...

Epilepsy is a treatable brain disease caused by short-term brain dysfunction that affects approximately 1 percent of the world's population. ...